中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 2
Mar.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(2): 444-447

Association between cancer-associated fibroblasts and liver cancer

DOI: 10.3969/j.issn.1001-5256.2021.02.041
  • 1.

    Graduate School, Guangxi University of Chinese Medicine, Nanning 530001, China

  • 2.

    First Ward of Liver Diseases, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530023, China

  • Received Date: 2020-08-07
  • Accepted Date: 2020-09-11
  • Published Date: 2021-02-20
    Abstract
  • Liver cancer has always been a threat to national health since liver disease has a high incidence rate in China. At present, methods for the prevention and treatment of liver cancer have unsatisfactory effects in clinical practice, and with in-depth studies, scholars have changed their focus to cancer-associated fibroblasts (CAFs) in tumor microenvironment. More and more evidence has shown that CAFs may provide a new target for the prevention and treatment of liver cancer. This article summarizes the role of CAFs in the development and progression of liver cancer and the potential of CAFs in the treatment of liver cancer.

     

    • FullText(HTML)
  • loading
    • References(35)
  • [1]
    Department of Medical Administration, National Health and Health Commission of the People's Republic of China. Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)[J]. J Clin Hepatol, 2020, 36(2): 277-292. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2020.02.007

    中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 临床肝胆病杂志, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007
    [2]
    LIU LY, LIU KK, ZHANG WW, et al. Advances in the role of cytokines secreted by tumor-associated macrophages in tumor microenvironment[J]. China Med Herald, 2019, 16(11): 30-33. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201911008.htm

    刘璐瑶, 刘可可, 张雯雯, 等. 肿瘤相关巨噬细胞分泌的细胞因子在肿瘤微环境中作用的研究进展[J]. 中国医药导报, 2019, 16(11): 30-33. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201911008.htm
    [3]
    ARNETH B. Tumor microenvironment[J]. Medicina (Kaunas), 2019, 56(1): 15. DOI: 10.3390/medicina56010015
    [4]
    HUANG SJ, QIU XD, LI WY, et al. Cellular crosstalk and tumorigenic mechanisms in tumor microenvironment[J]. Chin Bull Life Sci, 2020, 32(4): 315-324. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-SMKX202004003.htm

    黄思佳, 邱旭东, 李文彦, 等. 肿瘤微环境中的细胞调控网络及促瘤机制[J]. 生命科学, 2020, 32(4): 315-324. https://www.cnki.com.cn/Article/CJFDTOTAL-SMKX202004003.htm
    [5]
    ZHANG WW, LIU KK, LIU LY, et al. Advance research on the role of cancer -associated fibroblasts in oral squamous cell carcinoma and its targeted therapy[J]. China Med Herald, 2019, 16(14): 29-32. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201914009.htm

    张雯雯, 刘可可, 刘璐瑶, 等. 肿瘤相关成纤维细胞在口腔鳞状细胞癌中的作用及其靶向治疗的研究进展[J]. 中国医药导报, 2019, 16(14): 29-32. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201914009.htm
    [6]
    AFFO S, YU LX, SCHWABE RF. The role of cancer-associated fibroblasts and fibrosis in liver cancer[J]. Annu Rev Pathol, 2017, 12: 153-186. DOI: 10.1146/annurev-pathol-052016-100322
    [7]
    FENG RX, CHEN S, LIU J, et al. Effect of cancer-associated fibroblasts on cancer stem cells in hepatocellular carcinoma[J]. Chin J Gastroenter, 2016, 21(9): 517-522. (in Chinese) DOI: 10.3969/j.issn.1008-7125.2016.09.002

    冯仁鑫, 陈升, 刘娇, 等. 肿瘤相关成纤维细胞对肝癌干细胞的影响[J]. 胃肠病学, 2016, 21(9): 517-522. DOI: 10.3969/j.issn.1008-7125.2016.09.002
    [8]
    LI Y, WANG R, XIONG S, et al. Cancer-associated fibroblasts promote the stemness of CD24+ liver cells via paracrine signaling[J]. J Mol Med (Berl), 2019, 97(2): 243-255. DOI: 10.1007/s00109-018-1731-9
    [9]
    SHA M, JEONG S, GU JY, et al. Isolation, purification and identification of human intrahepatic cholangiocarcinoma-associated fibroblasts and its effect on proliferation and migration of cholangiocarcinoma cells[J]. Chin Hepatol, 2017, 22(6): 517-522. (in Chinese) DOI: 10.3969/j.issn.1008-1704.2017.06.013

    沙朦, Jeong Seogsong, 顾劲扬, 等. 人肝内胆管癌相关成纤维细胞的分离、纯化和鉴定及对胆管癌细胞生长和迁移的影响[J]. 肝脏, 2017, 22(6): 517-522. DOI: 10.3969/j.issn.1008-1704.2017.06.013
    [10]
    SUN HR, ZHANG Y, DU LB, et al. Isolation, culture and identification of hepatocellular carcinoma-associated fibroblast and its effect on the biological function of hepatocellular carcinoma cells[J]. Cancer Res Clinic, 2017, 29(8): 505-509. (in Chinese) DOI: 10.3760/cma.j.issn.1006-9801.2017.08.001

    孙浩然, 张钰, 杜鲁巴, 等. 肝癌中肿瘤相关成纤维细胞的分离、培养、鉴定及其对肝癌细胞生物学功能的影响[J]. 肿瘤研究与临床, 2017, 29(8): 505-509. DOI: 10.3760/cma.j.issn.1006-9801.2017.08.001
    [11]
    LAU EY, LO J, CHENG BY, et al. Cancer-associated fibroblasts regulate tumor-initiating cell plasticity in hepatocellular carcinoma through c-Met/FRA1/HEY1 signaling[J]. Cell Rep, 2016, 15(6): 1175-1189. DOI: 10.1016/j.celrep.2016.04.019
    [12]
    DENG Y, CHENG J, FU B, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells[J]. Oncogene, 2017, 36(8): 1090-1101. DOI: 10.1038/onc.2016.273
    [13]
    LIU Z, CHEN M, ZHAO R, et al. CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma[J]. Acta Biochim Biophys Sin (Shanghai), 2020, 52(1): 18-25. DOI: 10.1093/abbs/gmz134
    [14]
    HUANG B, HUANG M, LI Q. Cancer-associated fibroblasts promote angiogenesis of hepatocellular carcinoma by VEGF-mediated EZH2/VASH1 pathway[J]. Technol Cancer Res Treat, 2019, 18: 1533033819879905.
    [15]
    LU Y, LIN N, CHEN ZJ, et al. Correlation between human hepatocellular carcinoma associated fibroblast and angiogenesis in hepatocellular carcinoma[J/CD]. Chin J Hepat Surg (Electronic Edition), 2017, 6(3): 228-232. (in Chinese)

    卢逸, 林楠, 陈之巨, 等. 人肝癌相关成纤维细胞与肝癌血管生成的相关性研究[J/CD]. 中华肝脏外科手术学电子杂志, 2017, 6(3): 228-232.
    [16]
    LI Y, XU YJ, BAO ML. Expression of hepatoma-associated fibroblasts in human hepatocellular carcinoma tissues and its relationship with microvessel density[J]. Shanghai Med J, 2018, 41(6): 344-348. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-SHYX201806010.htm

    李艳, 徐永建, 鲍明亮. 肝癌相关成纤维细胞在人肝细胞癌组织中的表达情况及其与微血管密度的关系[J]. 上海医学, 2018, 41(6): 344-348. https://www.cnki.com.cn/Article/CJFDTOTAL-SHYX201806010.htm
    [17]
    ZHANG X, ZHANG J, ZHOU H, et al. Molecular mechanisms and anticancer therapeutic strategies in vasculogenic mimicry[J]. J Cancer, 2019, 10(25): 6327-6340. DOI: 10.7150/jca.34171
    [18]
    HE XJ, ZHANG ZS, CHEN GY, et al. Predictive value of vasculogenic mimicry in transcatheter arterial chemoembolization on primary hepatocellularcarcinoma[J]. J Lanzhou Univ (Medical Sciences), 2020, 46(1): 30-35, 41. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-LZYX202001007.htm

    何学军, 张志胜, 陈高阳, 等. 血管拟态在原发性肝癌经动脉栓塞化疗疗效及预后中的评估价值[J]. 兰州大学学报(医学版), 2020, 46(1): 30-35, 41. https://www.cnki.com.cn/Article/CJFDTOTAL-LZYX202001007.htm
    [19]
    TAO MZ, HU SY, GUO QX, et al. Relationship and clinical significance between α-SMA+ CAFs in hepatocellular carcinoma tissues and vasculogenic mimicry[J]. J Mod Oncol, 2019, 27(23): 4234-4237. (in Chinese) DOI: 10.3969/j.issn.1672-4992.2019.23.025

    陶明珠, 胡书娅, 郭庆喜, 等. 肝细胞癌组织中肿瘤相关成纤维细胞与血管生成拟态的相关性及临床意义[J]. 现代肿瘤医学, 2019, 27(23): 4234-4237. DOI: 10.3969/j.issn.1672-4992.2019.23.025
    [20]
    YANG J, LU Y, LIN YY, et al. Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma[J]. Cancer Lett, 2016, 383(1): 18-27. DOI: 10.1016/j.canlet.2016.09.012
    [21]
    HUA XF, LI TJ, JIA CC, et al. Effect of hepatocellular carcinoma associated fibroblasts to hepatocellular carcinoma[J/CD]. Chin J Hepat Surg (Electronic Edition), 2013, 2(3): 194-199. (in Chinese)

    华学锋, 李团结, 贾昌昌, 等. 肝癌相关成纤维细胞对肝细胞肝癌影响的实验研究[J/CD]. 中华肝脏外科手术学电子杂志, 2013, 2(3): 194-199.
    [22]
    FANG T, LV H, LV G, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer[J]. Nat Commun, 2018, 9(1): 191. DOI: 10.1038/s41467-017-02583-0
    [23]
    ZHANG Z, LI X, SUN W, et al. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis[J]. Cancer Lett, 2017, 397: 33-42. DOI: 10.1016/j.canlet.2017.03.004
    [24]
    SHA M, JEONG S, QIU BJ, et al. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma[J]. Cancer Med, 2018, 7(9): 4665-4677. DOI: 10.1002/cam4.1704
    [25]
    ZHANG XF, DONG M, PAN YH, et al. Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma[J]. Hum Pathol, 2017, 65: 92-100. DOI: 10.1016/j.humpath.2017.04.014
    [26]
    WU W, MENG N, PAN ZJ, et al. Cancer associated fibroblasts promotes cancer metastasis in cholangiocarcinoma RBE cells[J]. Chin J Exp Surg, 2019, 36(7): 1211-1214. (in Chinese)

    武伟, 孟柠, 潘志坚, 等. 胆管癌相关成纤维细胞对人胆管癌细胞转移的影响[J]. 中华实验外科杂志, 2019, 36(7): 1211-1214.
    [27]
    LIU J, CHEN S, WANG W, et al. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways[J]. Cancer Lett, 2016, 379(1): 49-59.
    [28]
    SUN L, WANG Y, WANG L, et al. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP[J]. J Exp Clin Cancer Res, 2019, 38(1): 170.
    [29]
    WANG Y, GAN G, WANG B, et al. Cancer-associated fibroblasts promote irradiated cancer cell recovery through autophagy[J]. EBioMedicine, 2017, 17: 45-56.
    [30]
    ZHAO Z, BAI S, WANG R, et al. Cancer-associated fibroblasts endow stem-like qualities to liver cancer cells by modulating autophagy[J]. Cancer Manag Res, 2019, 11: 5737-5744.
    [31]
    MADSEN CD, PEDERSEN JT, VENNING FA, et al. Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis[J]. EMBO Rep, 2015, 16(10): 1394-1408.
    [32]
    MERTENS JC, FINGAS CD, CHRISTENSEN JD, et al. Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma[J]. Cancer Res, 2013, 73(2): 897-907.
    [33]
    YU L, LIU Q, HUO J, et al. Cancer-associated fibroblasts induce immunotherapy resistance in hepatocellular carcinoma animal model[J]. Cell Mol Biol (Noisy-le-grand), 2020, 66(2): 36-40.
    [34]
    TAN J, YANG YT, SUN WJ, et al. The functional heterogeneity and source diversity of cancer associated fibroblasts[J]. Chin J Pathol, 2020, 49(7): 764-767. (in Chinese)

    谈静, 杨玉婷, 孙文杰, 等. 癌相关成纤维细胞的功能异质性与来源多样性[J]. 中华病理学杂志, 2020, 49(7): 764-767.
    [35]
    GAO YJ, YAO Y, SONG QB, et al. Research progress in activation mechanism of cancer-associated fibroblasts[J]. J Chin Oncol, 2019, 25(5): 453-457. (in Chinese)
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (335) PDF downloads(42) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return